AIDS, HIV & STDs Market Research Reports & Industry Analysis
HIV (human immunodeficiency virus) is a virus that attacks the immune system, making it difficult for the body to fight off infection and diseases. HIV infection eventually results in AIDS (acquired immunodeficiency syndrome). This conversion to AIDS may result after 12 or 13 years after the initial infection. Initial HIV symptoms are similar to those of the flu and include fatigue, fever, weight loss, and swollen lymph nodes in the neck, armpits, or groin. Although there is currently no cure for HIV infection, a combination of medications called Highly Active AntiRetroviral Therapy (HAART), and now referred to as AART, helps prolong life in many people. As noted above, person with HIV infection may live for many years before developing any signs of AIDS.
While HIV/AIDS isn’t found in the headlines as much as during the disease’s discovery, more people in the United States are living with HIV/AIDS than ever before. While the incidence of HIV infection in the United States was approximately 0.25% of the population ten to fifteen years ago, it is now approximately 0.47% -- and the population in general has grown.
For this reason, it is important to understand the trends in HIV/AIDS epidemiology and the potential impacts on economies and societies as a whole. These trends emphasize the strategic need for preventive approaches, clinical testing technologies and products, and new therapeutics. Many market research reports provide such information.
AIDS, HIV & STDs Industry Research & Market Reports
-
HIV Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
... and sexual contact. It is a virus which attacks immune cells known as CD-4 cells, making body susceptible to infections and other diseases. Over the years, the rising prevalence of HIV disease worldwide has positively ... Read More
-
UK HIV/AIDS Diagnostics Market Shares and Segment Forecasts, 2019-2023: HIV 1/2, Combo, Ag, NAT, Western Blot
... other confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs - Blood Banks - Public Health Labs - Physician Offices The DataPack also provides sales and market share estimates for major ... Read More
-
US HIV/AIDS Diagnostics Market Shares and Segment Forecasts: HIV 1/2, Combo, Ag, NAT, Western Blot
... confirmatory assays performed in the following market segments: - Hospitals - Commercial/Private Labs - Blood Banks - Public Health Labs - Physician Offices The DataPack provides sales and market Share estimates for major suppliers of ... Read More
-
Global Antiretroviral Drugs Market: Analysis By Drug Type (Multi-Class Drugs Combination Drugs, NRTI, NNRTI, Protease Inhibitors), By Region, By Country, Drug Forecast (2019 Edition): Opportunities and Forecast (2013-2023) - By Region (North America, Euro
... APAC, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India, South Africa) Executive Summary A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, ... Read More
-
Gonorrhea - Pipeline Review, H1 2019
... is a sexually transmitted disease (STD) caused by Neisseria gonorrhoeae bacterium. It can infect both males and females. The bacteria target the cells of the mucous membranes including surfaces of the urethra, vagina, cervix and ... Read More
-
Genital Herpes - Pipeline Review, H1 2019
... pipeline landscape. Genital herpes is a common sexually transmitted infection that affects both men and women. Genital herpes is caused by the herpes simplex virus (HSV). Symptoms include decreased appetite, fever, general sick feeling (malaise), ... Read More
-
2019 Europe Sexually-Transmitted Diseases (STDs): Emerging Opportunities in France, Germany, Italy, Spain, UK - Supplier Shares and Sales Segment Forecasts - Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis-
... analysis of the European sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in ... Read More
-
2019 Global Sexually-Transmitted Diseases (STDs): Emerging Opportunities in US, Europe, Japan - Supplier Shares and Sales Segment Forecasts by Country - Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis
... 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of ... Read More
-
2019 Global HIV/AIDS Diagnostics Market: Emerging Opportunities in US, Europe, Japan - Supplier Shares and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Strategies
... market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses are reviewed. The report provides the 5-year test volume ... Read More
-
2019-2023 U.K. Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts
... Chancroid , Chlamydia , Gonorrhea , Herpes ( I/II, VI ), Papillomavirus ( Pap Smear, HPV ), and Syphilis . The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. ... Read More
-
2019-2023 U.K. HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot - Supplier Shares and Country Segment Forecasts
... The report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks ... Read More
-
2019-2023 U.S. HIV/AIDS Diagnostic Testing Market: HIV 1/2, Combo, Ag, NAT, Western Blot - Supplier Shares and Country Forecasts
... report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/HIV NAT , Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments: - Hospitals - Commercial/Private Laboratories - Blood Banks - Physician ... Read More
-
2019-2023 U.S. Sexually-Transmitted Diseases (STD): Supplier Shares and Country Forecasts
... Chancroid , Chlamydia , Gonorrhea , Herpes ( I/II, VI ), Papillomavirus ( Pap Smear, HPV ), and Syphilis . The report provides test volume and sales projections for Hospitals, Commercial, Physician Offices, and Public ... Read More
-
2019-2023 Competing in the Global Sexually-Transmitted Disease (STD)Testing Market
... forecasts by country, market shares, and strategic profiles of leading suppliers. The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on ... Read More
-
The 2020-2025 World Outlook for HIV/AIDS Confirmatory Tests
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2020-2025 World Outlook for Syphilis Testing
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for Human Immunodeficiency Virus (HIV) Treatments
... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More
-
The 2020-2025 World Outlook for HIV/AIDS Testing
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2020-2025 World Outlook for HIV/AIDS Monitoring Test
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2020-2025 World Outlook for Sexually Transmitted Diseases (STD) Treatments and Diagnoses
... reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the ... Read More
-
The 2020-2025 World Outlook for HIV and AIDS Therapeutics
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2020-2025 World Outlook for Herpes Simplex Virus Treatments
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2020-2025 World Outlook for Sexually Transmitted Disease (STD) Diagnostic Testing
... are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These ... Read More
-
The 2020-2025 World Outlook for HIV and AIDS Testing
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
Chlamydia Infections Global Clinical Trials Review, H2, 2018
... line data relating to the clinical trials on Chlamydia Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical ... Read More
